• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by CME Group Inc.

    9/16/25 4:01:42 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance
    Get the next $CME alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001952996
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CME GROUP INC.
    SEC File Number
    001-31553
    Address of Issuer
    20 South Wacker Drive
    Chicago
    ILLINOIS
    60606
    Phone
    (312) 930-1000
    Name of Person for Whose Account the Securities are To Be Sold
    JONATHAN MARCUS
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    37697368.9636037704209/16/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common09/15/2025Restricted StockISSUERCheckbox not checked37609/15/2025Not Applicable

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    09/16/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    02/18/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Jonathan Marcus

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CME alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CME

    DatePrice TargetRatingAnalyst
    7/24/2025$305.00Buy → Neutral
    UBS
    4/8/2025$301.00Equal-Weight → Overweight
    Morgan Stanley
    3/10/2025$287.00Mkt Perform → Outperform
    Raymond James
    1/6/2025$255.00 → $250.00Buy → Neutral
    Citigroup
    10/8/2024$244.00Buy → Neutral
    Redburn Atlantic
    9/27/2024$235.00Sector Perform
    RBC Capital Mkts
    9/26/2024$221.00Hold
    TD Cowen
    9/3/2024$212.00 → $177.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $CME
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sr MD Chief Commercial Officer Winkler Julie was granted 3,044 units of Common Stock Class A and covered exercise/tax liability with 1,460 units of Common Stock Class A, increasing direct ownership by 7% to 25,512 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/17/25 1:49:19 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Chief Information Officer Cutinho Sunil covered exercise/tax liability with 1,496 units of Common Stock Class A and was granted 3,044 units of Common Stock Class A, increasing direct ownership by 9% to 18,988 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/17/25 1:49:25 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Chief Transformation Officer Vroman Ken was granted 2,608 units of Common Stock Class A and covered exercise/tax liability with 1,296 units of Common Stock Class A, increasing direct ownership by 7% to 20,070 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    9/17/25 1:49:13 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CME Group to Launch Options on Solana and XRP Futures

    CHICAGO, Sept. 17, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch options on Solana (SOL) and XRP futures on October 13, 2025, pending regulatory review. With the launch of these new products, clients will have the ability to trade options on SOL, Micro SOL, XRP, and Micro XRP futures, with expiries available every day of the business week, every month and every quarter. "The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures," said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. "Available in two different sizes,

    9/17/25 10:05:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Adjusted Interest Rate Total Return Futures Reach Record Open Interest of 1 Million Contracts

    CHICAGO, Sept. 16, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that its suite of Adjusted Interest Rate (AIR) Total Return futures reached an open interest (OI) record of more than 1 million contracts (equivalent to $365 billion notional) as well as a single-day volume record of 109,000 contracts (equivalent to $40 billion notional) on September 11. In addition, AIR Total Return futures average daily volume stands at a record 25,000 contracts for 2025, up 80% year-over-year. "More institutional investors are turning to our AIR Total Return futures to access U.S. index returns while mitigating interest rate, balance sheet and counterparty risk

    9/16/25 1:07:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Launches Analytics to Empower Volatility Traders In Increasingly Active Options Market

    CHICAGO, Sept. 9, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will provide market participants with enhanced tools to analyze options market data, facilitating more informed trading strategies and risk management. The new dataset includes essential options "Greeks" (Delta, Gamma, Theta, Vega, Rho) and implied volatility, supporting clients across a range of needs including portfolio analytics, risk modelling, market making, and quantitative research.  It is available in real-time and as historical data for all option expiries tied to the top 40 futures contracts traded at CME Group, covering every major asset class. "As global traders incr

    9/9/25 9:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    SEC Filings

    View All

    SEC Form 144 filed by CME Group Inc.

    144 - CME GROUP INC. (0001156375) (Subject)

    9/16/25 4:01:42 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. filed SEC Form 8-K: Leadership Update

    8-K - CME GROUP INC. (0001156375) (Filer)

    9/11/25 12:06:44 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. filed SEC Form 8-K: Other Events

    8-K - CME GROUP INC. (0001156375) (Filer)

    7/25/25 4:19:56 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CME Group downgraded by UBS with a new price target

    UBS downgraded CME Group from Buy to Neutral and set a new price target of $305.00

    7/24/25 7:57:18 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded CME Group from Equal-Weight to Overweight and set a new price target of $301.00

    4/8/25 9:08:11 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group upgraded by Raymond James with a new price target

    Raymond James upgraded CME Group from Mkt Perform to Outperform and set a new price target of $287.00

    3/10/25 7:18:35 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shepard William R was granted 879 units of Common Stock Class A and bought $72,336 worth of Common Stock Class A (267 units at $270.53), increasing direct ownership by 0.46% to 2,455 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    6/26/25 6:11:41 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Director Shepard William R bought $71,995 worth of Common Stock Class A (274 units at $262.62), increasing direct ownership by 0.48% to 2,443 units (SEC Form 4)

    4 - CME GROUP INC. (0001156375) (Issuer)

    3/27/25 7:19:14 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    Amendment: Director Shepard William R bought $324,198 worth of Common Stock Class A (1,422 units at $227.96), increasing direct ownership by 3% to 2,432 units (SEC Form 4)

    4/A - CME GROUP INC. (0001156375) (Issuer)

    3/27/25 6:55:07 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Financials

    Live finance-specific insights

    View All

    CME Group Inc. Announces Third-Quarter 2025 Earnings Release, Conference Call

    CHICAGO, Sept. 5, 2025 /PRNewswire/ -- CME Group Inc. will announce earnings for the third quarter of 2025 before the markets open on Wednesday, October 22, 2025. Written highlights for the quarter will be posted on the company's website at 6:00 a.m. Central Time, the same time it provides its earnings press release. The company will also hold an investor conference call that day at 7:30 a.m. Central Time, at which time company executives will take analysts' questions.  A live audio Webcast of the conference call will be available on the Investor Relations section of the company's website. Following the conference call, an archived recording will be available at the same site. Those wishing

    9/5/25 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Declares Quarterly Dividend

    CHICAGO, Aug. 7, 2025 /PRNewswire/ -- CME Group Inc., the world's leading derivatives marketplace, today declared a third-quarter dividend of $1.25 per share. The dividend is payable September 25, 2025, to shareholders of record as of September 9, 2025. As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy

    8/7/25 7:30:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

    Record revenue of $1.7 billion, up 10% from Q2 2024Record average daily volume (ADV) of 30.2 million contracts, up 16% from Q2 2024CHICAGO, July 23, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today reported financial results for the second quarter of 2025. The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2025. Net income was $1.0 billion and diluted earnings per common share were $2.81. On an adjusted basis, net income was $1.1 billion and diluted earnings per common share were $2.96. Financial results presented on an adjusted basis for the second quarter of 2025 and 2024 exclude certain items, which are detailed in the reconc

    7/23/25 7:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Financial Institutions to Join BrokerTec Chicago for First Day of Trading

    New Central Limit Order Book for U.S. Treasury Trading to Launch Oct. 6CHICAGO, Sept. 4, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that Citigroup, J.P. Morgan and Morgan Stanley will be available to trade cash U.S. Treasuries on BrokerTec Chicago when it launches on October 6. "With leading financial firms on board for day one on BrokerTec Chicago, trading U.S. Treasury futures and cash will be more efficient than ever before," said Mike Dennis, CME Group Global Head of Fixed Income. "CME Group is in a unique position to bring these markets together, unlocking value for our clients worldwide who want to more precisely hedge their risk amid

    9/4/25 8:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Group Inc. Announces Preliminary Results from its 2025 Annual Meeting of Shareholders

    CHICAGO, May 9, 2025 /PRNewswire/ -- CME Group Inc. (NASDAQ:CME) today announced the preliminary shareholder voting results from its 2025 annual meeting. At the meeting, shareholders: Elected Terrence A. Duffy, Kathryn Benesh, Timothy S. Bitsberger, Charles P. Carey, Bryan T. Durkin, Harold Ford Jr., Martin J. Gepsman, Daniel G. Kaye, Phyllis M. Lockett, Deborah J. Lucas, Rahael Seifu, William R. Shepard, Howard J. Siegel and Dennis A. Suskind, each for a one-year term expiring in 2026.Ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025.Approved, on an advisory basis, the compensation of our named executive officers.There was

    5/9/25 10:29:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    CME Clearing Appoints New Chief Risk Officer

    CHICAGO, April 24, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the appointment of Vijay Albuquerque as Chief Risk Officer (CRO) in its Clearing & Post-Trade Services Division.  With over 20 years' industry experience, Albuquerque most recently served as the Head of Counterparty Risk and Portfolio Risk Analytics for Citigroup's Markets and Banking businesses. Albuquerque will be based in New York and will report to Suzanne Sprague, CME Group Chief Operating Officer and Global Head of Clearing. "Vijay's deep expertise in both derivatives and securities markets will be invaluable as we continue to deliver leading risk management services to our

    4/24/25 4:00:00 AM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    $CME
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/24 5:02:29 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/13/23 2:49:27 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G/A filed by CME Group Inc. (Amendment)

    SC 13G/A - CME GROUP INC. (0001156375) (Subject)

    2/11/22 3:04:00 PM ET
    $CME
    Investment Bankers/Brokers/Service
    Finance